Skip to main content

Table 3 Burden Assessment Scale,a Paliperidone Palmitate Group

From: Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study

 

Baseline

Week 9

Week 25

All patients (observed cases)

 Total score, patients, n

96

46

33

  Mean (SD)

38.9 (14.4)

31.3 (13.0)

31.5 (13.0)

  Change from baseline, mean (SD)

–

−8.8 (11.9)

−9.2 (14.6)

Patients who completed 25 weeks of treatmentb

 Total score, patients, n

33

31

33

  Mean (SD)

40.6 (13.5)

30.6 (13.2)

31.5 (13.0)

  Change from baseline, mean (SD)

–

−9.9 (13.2)

−9.2 (14.6)

  1. aRange: 19–76
  2. bAll patients who had Burden Assessment Scale data at baseline and week 25